imatinib mesylate has been researched along with Brain Stem Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandru, D; Bota, DA; Van Horn, DK | 1 |
| Banerjee, A; Blaney, SM; Boyett, JM; Friedman, H; Geyer, JR; Goldman, S; Hancock, ML; Hayes, M; Jakacki, RI; Kieran, MW; Krasin, MJ; Kun, LE; Murgo, A; Packer, R; Phillips, P; Pollack, IF; Poussaint, TY; Wang, Y; Weiner, S | 1 |
1 trial(s) available for imatinib mesylate and Brain Stem Neoplasms
| Article | Year |
|---|---|
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.
Topics: Adolescent; Adult; Antineoplastic Agents; Benzamides; Brain Stem Neoplasms; Child; Child, Preschool; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Glioma; Humans; Imatinib Mesylate; Male; Piperazines; Pyrimidines; Recurrence; Survival Analysis | 2007 |
1 other study(ies) available for imatinib mesylate and Brain Stem Neoplasms
| Article | Year |
|---|---|
Secondary fibrosarcoma of the brain stem treated with cyclophosphamide and Imatinib.
Topics: Antineoplastic Agents; Benzamides; Brain Stem Neoplasms; Cyclophosphamide; Fibrosarcoma; Glial Fibrillary Acidic Protein; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Piperazines; Pyrimidines; S100 Proteins | 2010 |